Michael F Gerhards
Overview
Explore the profile of Michael F Gerhards including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
2404
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bond M, Verhoef C, Kazemier G, Kok N, Gerhards M, Kuhlmann K, et al.
Eur J Surg Oncol
. 2025 Feb;
51(6):109681.
PMID: 40014958
Background: Patients with colorectal liver-only metastases (CRLM) eligible for local treatment (resection/ablation) do not always receive this potentially curative treatment due to the lack of clear resectability criteria and expertise...
2.
Pilz da Cunha G, Sijberden J, van Dieren S, Gobardhan P, Lips D, Terkivatan T, et al.
Ann Surg Open
. 2024 Dec;
5(4):e527.
PMID: 39711656
Objective: To compare nationwide outcomes of robotic liver resection (RLR) with laparoscopic liver resection (LLR). Background: Minimally invasive liver resection is increasingly performed using the robotic approach as this could...
3.
Bond M, Bolhuis K, Loosveld O, de Groot J, Droogendijk H, Helgason H, et al.
JAMA Oncol
. 2024 Nov;
11(1):36-45.
PMID: 39570583
Importance: In patients with colorectal cancer and unresectable liver-only metastases (CRLM), treatment with folinic acid, fluorouracil, and oxaliplatin (FOLFOX) plus irinotecan (FOLFOXIRI) and bevacizumab vs FOLFOX/folinic acid, fluorouracil, and irinotecan...
4.
Pilz da Cunha G, Sijberden J, Gobardhan P, Lips D, Terkivatan T, Marsman H, et al.
Surgery
. 2024 Oct;
178():108820.
PMID: 39384481
Background: Unfavorable intraoperative findings or incidents during minimally invasive liver surgery may necessitate conversion to open surgery. This study aimed to identify predictors for conversion in minimally invasive liver surgery...
5.
Michiel Zeeuw J, Wesdorp N, Ali M, Bakker A, Voigt K, Starmans M, et al.
Eur J Cancer
. 2024 Jun;
207:114185.
PMID: 38924855
Background: This study aimed to assess the prognostic value of total tumor volume (TTV) for early recurrence (within 6 months) and overall survival (OS) in patients with colorectal liver metastases...
6.
Park J, Lafaro K, Hagendoorn J, Melstrom L, Gerhards M, Gorgec B, et al.
J Am Coll Surg
. 2024 May;
239(1):61-67.
PMID: 38770933
Background: For open minor hepatectomy, morbidity and recovery are dominated by the incision. The robotic approach may transform this "incision dominant procedure" into a safe outpatient procedure. Study Design: We...
7.
Achterberg F, Bijlstra O, Slooter M, Sibinga Mulder B, Boonstra M, Bouwense S, et al.
JAMA Netw Open
. 2024 Apr;
7(4):e246548.
PMID: 38639939
Importance: Unintended tumor-positive resection margins occur frequently during minimally invasive surgery for colorectal liver metastases and potentially negatively influence oncologic outcomes. Objective: To assess whether indocyanine green (ICG)-fluorescence-guided surgery is...
8.
de Graaff M, Klaase J, den Dulk M, Te Riele W, Hagendoorn J, Van Heek N, et al.
HPB (Oxford)
. 2024 Mar;
26(6):789-799.
PMID: 38461070
Background: Approximately 70% of patients with colorectal liver metastases (CRLM) experiences intrahepatic recurrence after initial liver resection. This study assessed outcomes and hospital variation in repeat liver resections (R-LR). Methods:...
9.
Wesdorp N, Michiel Zeeuw J, Postma S, Roor J, van Waesberghe J, van den Bergh J, et al.
Eur Radiol Exp
. 2023 Dec;
7(1):75.
PMID: 38038829
Background: We developed models for tumor segmentation to automate the assessment of total tumor volume (TTV) in patients with colorectal liver metastases (CRLM). Methods: In this prospective cohort study, pre-...
10.
Wesdorp N, Bolhuis K, Roor J, van Waesberghe J, van Dieren S, van Amerongen M, et al.
Ann Surg Open
. 2023 Aug;
2(4):e103.
PMID: 37637880
Objectives: Compare total tumor volume (TTV) response after systemic treatment to Response Evaluation Criteria in Solid Tumors (RECIST1.1) and assess the prognostic value of TTV change and RECIST1.1 for recurrence-free...